Amalgamated Financial’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Amalgamated Financial’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$101K	Buy	+4,545	New	+$116K	﹤0.01%	2144

Other funds holding INBX

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Amalgamated Financial's INBX Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Inhibrx, Inc. Common Stock (INBX) in Q1 2022: 4,545 shares worth $101K. The stake represents ﹤0.01% of the portfolio and ranks #2144 among its holdings.

99 funds tracked by Wall St. Rank hold INBX as of Q1 2022.

Amalgamated Financial held 4,545 shares of Inhibrx, Inc. Common Stock worth $101K as of Q1 2022.
Inhibrx, Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
Inhibrx, Inc. Common Stock made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2144 holding.
99 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.